Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States
Hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, 110th Congress, 1st Session, May 2, 2007, Serial No. 110-40
Other books by this author
Do you want to read a book that interests you? It’s EASY!
Create an account and send a request for reading to other users on the Webpage of the book!
